Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study
- 153 Downloads
The aims were to compare the precision (reliability) in single X-ray (SXA) and dual X-ray (DXA) absorptiometry, and to compare smallest detectable difference (SDD). An additional aim was to examine determinants for precision in bone mineral density (BMD). BMD was measured by SXA (DTX-100, Osteometer) in the forearm and by DXA (Lunar Expert) in the forearm and in the hip. Two measurements were performed at each site/method, and 195 of 207 participants had complete datasets. Participants were aged 47–49 and 71–74 years. The precision was estimated by Root Mean Square Standard Deviation (RMS SD) with 95% Confidence Interval (95%CI) and the corresponding coefficients of variation (CV%). Determinants (age, gender, BMD) were analysed by multiple linear regression with log (SD) and log (CV) as dependent variables. RMS SD tended to be largest in older women and in those with low BMD. RMS SD for SXA and DXA forearm was 4.6 (4.2–5.1) and 6.8 (6.1–7.4) and the corresponding CVs 1.0% and 1.4%. RMS SD for DXA hip was 11.0 (9.9–12.0) with CV 1.2%. To detect a 3% change in BMD one would need two repeated measurements by DXA in the distal forearm at each of two consultations, but only one measurement by SXA in the distal forearm and also only one measurement by DXA in the hip. Precision differed by type of densitometer affecting the number of repeated measurements needed to detect a given BMD difference.
KeywordsBone mineral density Single-energy X-ray absorptiometry Dual-energy X-ray absorptiometry Reliability Least significant change Smallest detectable difference
This study was supported by grants from the Norwegian Foundation for Health and Rehabilitation, Norwegian Osteoporosis Foundation, Norwegian Women’s Public Health Association, and Research Council of Norway. Economic support was also received from Astra Zeneca Norway; Merck, Sharpe & Dohme Norway; Norwegian Rheumatism Association; and TINE BA (Norwegian Dairy Industry). The data were collected in collaboration with the National Health Screening Service of Norway, now the Norwegian Institute of Public Health.
- 1.Weinstein M, Fineberg H, Elstein A. The value of clinical information. In: Weinstein M, Fineberg H, editors. Clinical decision analysis. Philadelphia: W.B. Saunders Company; 1980. p. 131–167.Google Scholar
- 5.Miller CG. Bone density measurements in clinical trials: the challenge of ensuring optimal data. Br J Clin Res. 1993;4:113–20.Google Scholar
- 7.Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815–22. doi: 10.1001/jama.286.22.2815.PubMedCrossRefGoogle Scholar
- 9.Johnston CC Jr, Slemenda CW. Identification of patients with low bone mass by single photon absorptiometry and single-energy X-ray absorptiometry. Am J Med. 1995;98:37S–40S. Review. 10.1016/S0002-9343(05)80044-0
- 10.Kleerekoper M, Nelson DA. Peripheral bone densitometry: an old friend revisited. Am Clin Climatol Assoc. 1998;109:62–70.Google Scholar
- 26.Expert-XI imaging densitometer––reference manual. Software v.1.7. Documentation version 2/98 E. Reference Manual Assembly P/N 17460, Lunar. 2 ed. 1998.Google Scholar
- 27.Osteometer DTX-100. Operator’s manual. 1MAN0510-B00. Osteometer A/S, Glerupvej 2, DK-2610 Rødovre, Denmark, System Software version 1.52. 1994.Google Scholar